Inside informationEnglish
NFL Biosciences announces results from a new study conducted with the CEA providing further insight into the effects of NFL-101, its first-in-class treatment for tobacco addiction, and highlighting its prolonged activity
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- NFL Biosciences
- Filed
- 05/05/2025, 08:29
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 078410_20250505